Seroresponse to Third Doses of SARS-CoV-2 Vaccine Among Patients Receiving Maintenance Dialysis.

Hsu, Caroline M; Lacson, Eduardo K; Manley, Harold J; Aweh, Gideon N; Miskulin, Dana; Johnson, Doug; Weiner, Daniel E

Hsu, Caroline M; Lacson, Eduardo K; Manley, Harold J; Aweh, Gideon N; Miskulin, Dana; Johnson, Doug; Weiner, Daniel E.

Afiliación

Hsu CM; Tufts Medical Center, Boston, Massachusetts. Electronic address: chsu1@tuftsmedicalcenter.org.
Lacson EK; Tufts Medical Center, Boston, Massachusetts; Dialysis Clinic, Inc., Nashville, Tennessee.
Manley HJ; Dialysis Clinic, Inc., Nashville, Tennessee.
Aweh GN; Dialysis Clinic, Inc., Nashville, Tennessee.
Miskulin D; Tufts Medical Center, Boston, Massachusetts.
Johnson D; Dialysis Clinic, Inc., Nashville, Tennessee.
Weiner DE; Tufts Medical Center, Boston, Massachusetts.

Am J Kidney Dis ; 80(1): 151-153, 2022 07.

Article en En | MEDLINE | ID: mdl-35378208

Asunto(s)

COVID-19; Diálisis Renal; Anticuerpos Antivirales; COVID-19/prevención & control; Vacunas contra la COVID-19; Humanos; SARS-CoV-2

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diálisis Renal / COVID-19 Límite: Humans Idioma: En Revista: Am J Kidney Dis Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google